J. Homolka (Prague, Czech Republic), A. Bossink (Den Dolder, Netherlands)
Retrial of identical agents in patients with toxic hepatitis caused by first line antituberculosis drugs
Y. H. Kim, H. S. Lee, J. S. Choi, K. H. Seo, H. G. Hwang, J. O. Na (Chunan, Gumi, Republic Of Korea)
|  |
Paradoxical reactions during treatment of tuberculosis: A prospective study
R. Breen, C. Smith, I. Cropley, M. Lipman (London, United Kingdom)
| |
Side effects at second line TB drugs – 2 years experience of multidrug-resistant tuberculosis department from Bucharest
V. Spinu, C. Popa, E. Ibraim (Bucharest, Romania)
| |
Desensitization therapy for allergic reactions of antituberculous drugs
Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan)
|  |
Adverse effects of MDR-TB treatment with a standardized regimen: A report from Iran
P. Baghaei, P. Tabarsi, M. Marjani, D. Mansouri, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
| |
Risk factors of drug -induced hepatitis among patients with TB/HIV co-infection
P. Tabarsi, P. Baghaei, M. Marjani, M. Shamaei, D. Mansouri, M. Masjedi (Tehran, Islamic Republic Of Iran)
| |
The effects of vitamin C supplementation aganist isoniazid-induced hepatotoxicity in rats
H. Uzun, I. Birincioglu, Y. Ergül, T. Erkan, H. Genc, R. Gelisgen, T. Altug (Istanbul, Turkey)
| |
A case of oral desensibilization in recurrent allergic reactions against intravenous paraaminosalicylic acid (PAS)
S. Vesenbeckh, J. Becker, C. Bürger, N. Schönfeld, T. Blum, T. Bauer (Berlin, Greifswald, Germany)
| |
Efeect of substitution of pyrazinamid by ofloxacin in patients who developed drug induced hepatitis with anti-tuberculosis drugs on mortalty and re-hepatitis
P. Tabarsi, P. Baghaei, M. Marjani, M. Shamaei, M. Masjedi (Tehran, Islamic Republic Of Iran)
| |
Rapid oral desensitization to anti-tuberculosis drugs
H. Daghfous, H. Zaibi, S. Merai, O. Kahloul, F. Tritar (Ariana, Tunisia)
| |
Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1st line
G. Hauadamova, E. Arbuzova, Y. Besstrashnova, G. Akbaeva (Almaty, Kazakhstan)
| |
Comparison of smear positive tuberculosis features in males with and without chronic lung diseases
N. Rahmouni, I. Aissa, A. Khattab, D. Ghorbel, I. Zendah, H. Ghedira (Ariana, Tunisia)
| |
Comorbidities impact on bacteriological exam in DOTS intensive phase
C. Marica, M. Popescu-Hagen, R. Macavei, V. Macavei (Bucharest, Romania)
| |
Pulmonary TB in asthma: A rare condition
R. Miron, A. Trofor, M. Sandu, T. Traian (Iasi, Romania)
| |
Treatment and outcome of CRF patients with tuberculosis
P. Baghaei, P. Tabarsi, M. Marjani, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
| |
Tuberculosis – An important risk factor for lung cancer
R. Rajnoveanu, C. Pop, M. Man, A. Rajnoveanu, A. Muresan, D. Homorodean (Cluj-Napoca, Brasov, Romania)
| |
Retrospective study of patients who developed asthma after tuberculosis
T. Sahasrabudhe, S. Meshram (Pune, India)
| |
The impact of ethambutol optic toxicity on treatment of MDR TB
M. Ledina, L. Ledina, T. Ledina, V. Milanovic (Sokobanja, Belgrade, Republic Of Serbia)
| |
Impact of psychiatric morbidity and personality trait on treatment completion and default in patients taking directly observed treatment for tuberculosis
A. Bansal, S. Chaudhri, S. S. Agnihotri, A. K. Verma, O. P. Rai, A. Sampath, A. Kumar, S. K. Verma (Kanpur, India)
| |
Hepato toxicity during antituberculosis treatment: A statiscal study about 13 cases
L. Nacef, O. Saighi (Algeria)
| |